Lv1
10 积分 2024-08-19 加入
P180 – Number Needed to Harm (NNH) in metastatic Hormone-Sensitive Prostate Cancer (mHSPC) – darolutamide (D), apalutamide (A) and enzalutamide (E) clinical trials
3个月前
已完结
P180 – Number Needed to Harm (NNH) in metastatic Hormone-Sensitive Prostate Cancer (mHSPC) – darolutamide (D), apalutamide (A) and enzalutamide (E) clinical trials
3个月前
已关闭
P185 – Skin rash induced by apalutamide correlated with age and relative dose intensity adjusted by body surface area in Japanese patients with prostate cancer
3个月前
已完结
P185 – Skin rash induced by apalutamide correlated with age and relative dose intensity adjusted by body surface area in Japanese patients with prostate cancer
3个月前
已关闭
ARDS due to acute daptomycin-induced eosinophilic pneumonia
3个月前
已完结
Bioequivalence and Safety of Two Oseltamivir Phosphate for Oral Suspension in Healthy Chinese Subjects Under Fasting and Fed Conditions: A Randomized, Open‑Label, Single‑Dose, Crossover Study
3个月前
已完结
ARDS due to acute daptomycin-induced eosinophilic pneumonia
3个月前
已关闭
AML-558: Low Rate of Fungal Infections in a Population of Elderly/Unfit AML Patients Receiving Azacitidine and Venetoclax Without Posaconazole Prophylaxis: A Monocentric Experience
4个月前
已关闭
AML-558: Low Rate of Fungal Infections in a Population of Elderly/Unfit AML Patients Receiving Azacitidine and Venetoclax Without Posaconazole Prophylaxis: A Monocentric Experience
4个月前
已关闭
Utilization of Intravenous Posaconazole in Pediatric Patients Undergoing Hematopoietic Stem Cell Transplant
4个月前
已完结
皖公网安备34019202002308
